• Patient Advocacy Groups Worldwide Plan Events to Mark Rare Disease Day, Feb. 28
  • Time to Stop Worrying About What People Think of Me
  • Emerald’s Cannabis-based Scleroderma Therapy Obtains Orphan Drug Status in Europe
  • NIAMS Awards 5 New Core Centers for Clinical Research, Including Scleroderma
  • If Only We Had More Investment in Medical Research
  • Appreciating the Dark and Light Sides of My Life
  • Rare Disease Groups, Patients Differ on ‘Right to Try’ Bill Before US Congress
  • Myeloablative Stem Cell Transplant Improves Long-term Outcomes in Severe Scleroderma, Trial Shows
  • How to Appreciate the Life We’re Given
  • Fibrocell Files New Drug Application for FCX-013 as Localized Scleroderma Therapy
  • My Social Dilemma: When Illness Hogs the Conversation
  • Risks of Radiation Therapy for Patients with Breast Cancer Examined in Study